|
1
|
Bataller R and Brenner DA: Liver fibrosis.
J Clin Invest. 115:209–218. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sánchez-Valle V, Chávez-Tapia NC, Uribe M
and Méndez-Sánchez N: Role of oxidative stress and molecular
changes in liver fibrosis: A review. Curr Med Chem. 19:4850–4860.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li JT, Liao ZX, Ping J, Xu D and Wang H:
Molecular mechanism of hepatic stellate cell activation and
antifibrotic therapeutic strategies. J Gastroenterol. 43:419–428.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schon HT, Bartneck M, Borkham-Kamphorst E,
Nattermann J, Lammers T, Tacke F and Weiskirchen R: Pharmacological
Intervention in Hepatic Stellate Cell Activation and Hepatic
Fibrosis. Front Pharmacol. 7:332016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghatak S, Biswas A, Dhali GK, Chowdhury A,
Boyer JL and Santra A: Oxidative stress and hepatic stellate cell
activation are key events in arsenic induced liver fibrosis in
mice. Toxicol Appl Pharmacol. 251:59–69. 2011. View Article : Google Scholar
|
|
6
|
Mormone E, George J and Nieto N: Molecular
pathogenesis of hepatic fibrosis and current therapeutic6
approaches. Chem Biol Interact. 193:225–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yasuda M, Shimizu I, Shiba M and Ito S:
Suppressive effects of estradiol on dimethylnitrosamine-induced
fibrosis of the liver in rats. Hepatology. 29:719–727. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu JW, Gong J, Chang XM, Luo JY, Dong L,
Hao ZM, Jia A and Xu GP: Estrogen reduces CCl4-induced
liver fibrosis in rats. World J Gastroenterol. 8:883–887. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimizu I, Mizobuchi Y, Yasuda M, Shiba M,
Ma YR, Horie T, Liu F and Ito S: Inhibitory effect of oestradiol on
activation of rat hepatic stellate cells in vivo and in vitro. Gut.
44:127–136. 1999. View Article : Google Scholar
|
|
10
|
Itagaki T, Shimizu I, Cheng X, Yuan Y,
Oshio A, Tamaki K, Fukuno H, Honda H, Okamura Y and Ito S: Opposing
effects of oestradiol and progesterone on intracellular pathways
and activation processes in the oxidative stress induced activation
of cultured rat hepatic stellate cells. Gut. 54:1782–1789. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cuzick J: Hormone replacement therapy and
the risk of breast cancer. Eur J Cancer. 44:2344–2349. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barnes PJ: Corticosteroids: The drugs to
beat. Eur J Pharmacol. 533:2–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee JK, Kim JH and Shin HK: Therapeutic
effects of the oriental herbal medicine Sho-saiko-to on liver
cirrhosis and carcinoma. Hepatol Res. 41:825–837. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng G, Kurtz RC, Vickers A, Lau N, Yeung
KS, Shia J and Cassileth B: A single arm phase II study of a
Far-Eastern traditional herbal formulation (sho-sai-ko-to or
xiao-chai-hu-tang) in chronic hepatitis C patients. J
Ethnopharmacol. 136:83–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin F, Liu JY and Yuan JH:
Chaihu-Shugan-San, an oriental herbal preparation, for the
treatment of chronic gastritis: A meta-analysis of randomized
controlled trials. J Ethnopharmacol. 146:433–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan J, Li X, Li P, Li N, Wang T, Shen H,
Siow Y, Choy P and Gong Y: Saikosaponin-d attenuates the
development of liver fibrosis by preventing hepatocyte injury.
Biochem Cell Biol. 85:189–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dang SS, Wang BF, Cheng YA, Song P, Liu ZG
and Li ZF: Inhibitory effects of saikosaponin-d on
CCl4-induced hepatic fibrogenesis in rats. World J
Gastroenterol. 13:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen MF, Huang CC, Liu PS, Chen CH and
Shiu LY: Saikosaponin a and saikosaponin d inhibit proliferation
and migratory activity of rat HSC-T6 cells. J Med Food. 16:793–800.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Ren J, Tang J, Zhang D, Li B and
Li Y: Estrogen-like activities of saikosaponin-d in vitro: A pilot
study. Eur J Pharmacol. 626:159–165. 2010. View Article : Google Scholar
|
|
20
|
Richter DU, Mylonas I, Toth B, Scholz C,
Briese V, Friese K and Jeschke U: Effects of phytoestrogens
genistein and daidzein on progesterone and estrogen (estradiol)
production of human term trophoblast cells in vitro. Gynecol
Endocrinol. 25:32–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gille JJ and Joenje H: Cell culture models
for oxidative stress: Superoxide and hydrogen peroxide versus
normobaric hyperoxia. Mutat Res. 275:405–414. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kiyoshima T, Enoki N, Kobayashi I, Sakai
T, Nagata K, Wada H, Fujiwara H, Ookuma Y and Sakai H: Oxidative
stress caused by a low concentration of hydrogen peroxide induces
senescence-like changes in mouse gingival fibroblasts. Int J Mol
Med. 30:1007–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coates D, Zafar S and Milne T:
Quantitative real-time gene profiling of human alveolar
osteoblasts. Methods Mol Biol. 1537:447–459. 2017. View Article : Google Scholar
|
|
24
|
Lechuga CG, Hernández-Nazara ZH, Domínguez
Rosales JA, Morris ER, Rincón AR, Rivas-Estilla AM, Esteban-Gamboa
A and Rojkind M: TGF-beta1 modulates matrix metalloproteinase-13
expression in hepatic stellate cells by complex mechanisms
involving p38MAPK, PI3-kinase, AKT, and p70S6k. Am J Physiol
Gastrointest Liver Physiol. 287:G974–G987. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iredale JP: Hepatic stellate cell behavior
during resolution of liver injury. Semin Liver Dis. 21:427–436.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang BZ, Guo XT, Chen JW, Zhao Y, Cong X,
Jiang ZL, Cao RF, Cui K, Gao SS and Tian WR: Saikosaponin-D
attenuates heat stress-induced oxidative damage in LLC-PK1 cells by
increasing the expression of anti-oxidant enzymes and HSP72. Am J
Chin Med. 42:1261–1277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao L, Zhang H, Bao J, Liu J and Ji Z:
Saikosaponin-d protects renal tubular epithelial cell against high
glucose induced injury through modulation of SIRT3. Int J Clin Exp
Med. 8:6472–6481. 2015.PubMed/NCBI
|
|
28
|
Hong IH, Park SJ, Goo MJ, Lee HR, Park JK,
Ki MR, Kim SH, Lee EM, Kim AY and Jeong KS: JNK1 and JNK2 regulate
α-SMA in hepatic stellate cells during CCl4-induced
fibrosis in the rat liver. Pathol Int. 63:483–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Varela-Rey M, Montiel-Duarte C,
Osés-Prieto JA, López-Zabalza MJ, Jaffrèzou JP, Rojkind M and
Iraburu MJ: p38 MAPK mediates the regulation of alpha1(I)
procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of
rat hepatic stellate cells(1). FEBS Lett. 528:133–138. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedman SL: Liver fibrosis - from bench
to bedside. J Hepatol. 38(Suppl 1): S38–S53. 2003. View Article : Google Scholar
|
|
31
|
Bhaskar ME: Management of cirrhosis and
ascites. N Engl J Med. 351:300–301; author reply 300-301, 2004.
PubMed/NCBI
|
|
32
|
O'Beirne JP, Foxton MR and Heneghan MA:
Management of cirrhosis and ascites. N Engl J Med. 351:300–301;
author reply 300-301, 2004. PubMed/NCBI
|
|
33
|
Xu JW, Gong J, Chang XM, Luo JY, Dong L,
Jia A and Xu GP: Effects of estradiol on liver estrogen
receptor-alpha and its mRNA expression in hepatic fibrosis in rats.
World J Gastroenterol. 10:250–254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li JF, Chen BC, Lai DD, Jia ZR, Andersson
R, Zhang B, Yao JG and Yu Z: Soy isoflavone delays the progression
of thioacetamide-induced liver fibrosis in rats. Scand J
Gastroenterol. 46:341–349. 2011. View Article : Google Scholar
|
|
35
|
Lee ES, Shin MO, Yoon S and Moon JO:
Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis
in rats. Arch Pharm Res. 33:925–932. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Demiroren K, Dogan Y, Kocamaz H, Ozercan
IH, Ilhan S, Ustundag B and Bahcecioglu IH: Protective effects of
L-carnitine, N-acetylcysteine and genistein in an experimental
model of liver fibrosis. Clin Res Hepatol Gastroenterol. 38:63–72.
2014. View Article : Google Scholar
|
|
37
|
Novo E, Busletta C, Bonzo LV, Povero D,
Paternostro C, Mareschi K, Ferrero I, David E, Bertolani C,
Caligiuri A, et al: Intracellular reactive oxygen species are
required for directional migration of resident and bone
marrow-derived hepatic pro-fibrogenic cells. J Hepatol. 54:964–974.
2011. View Article : Google Scholar
|
|
38
|
Marra F, Arrighi MC, Fazi M, Caligiuri A,
Pinzani M, Romanelli RG, Efsen E, Laffi G and Gentilini P:
Extracellular signal-regulated kinase activation differentially
regulates platelet-derived growth factor's actions in hepatic
stellate cells, and is induced by in vivo liver injury in the rat.
Hepatology. 30:951–958. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhong W, Shen WF, Ning BF, Hu PF, Lin Y,
Yue HY, Yin C, Hou JL, Chen YX, Zhang JP, et al: Inhibition of
extracellular signal-regulated kinase 1 by adenovirus mediated
small interfering RNA attenuates hepatic fibrosis in rats.
Hepatology. 50:1524–1536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Frémin C, Bessard A, Ezan F, Gailhouste L,
Régeard M, Le Seyec J, Gilot D, Pagès G, Pouysségur J, Langouët S,
et al: Multiple division cycles and long-term survival of
hepatocytes are distinctly regulated by extracellular
signal-regulated kinases ERK1 and ERK2. Hepatology. 49:930–939.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kluwe J, Pradere JP, Gwak GY, Mencin A, De
Minicis S, Österreicher CH, Colmenero J, Bataller R and Schwabe RF:
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase
inhibition. Gastroenterology. 138:347–359. 2010. View Article : Google Scholar :
|
|
42
|
Zhou Y, Shimizu I, Lu G, Itonaga M,
Okamura Y, Shono M, Honda H, Inoue S, Muramatsu M and Ito S:
Hepatic stellate cells contain the functional estrogen receptor
beta but not the estrogen receptor alpha in male and female rats.
Biochem Biophys Res Commun. 286:1059–1065. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Y, Liu J, Lin L, Que R, Shen Y and Tao
Z: Regulation of saikosaponin-d on the level of of ERα and ERβ
protein in hepatic stellate cells. Trad Chin Drug Res Clin
Pharmacol. 27:58–61. 2016.In Chinese.
|
|
44
|
Nadal- Serrano M, Pons DG, Sastre- Serra
J, Blanquer-Rosselló MM, Roca P and Oliver J: Genistein modulates
oxidative stress in breast cancer cell lines according to ERα/ERβ
ratio: Effects on mitochondrial functionality, sirtuins, uncoupling
protein 2 and antioxidant enzymes. Int J Biochem Cell Biol.
45:2045–2051. 2013. View Article : Google Scholar
|
|
45
|
Giddabasappa A, Bauler M, Yepuru M, Chaum
E, Dalton JT and Eswaraka J: 17-β estradiol protects ARPE-19 cells
from oxidative stress through estrogen receptor-β. Invest
Ophthalmol Vis Sci. 51:5278–5287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ortmann J, Veit M, Zingg S, Di Santo S,
Traupe T, Yang Z, Völzmann J, Dubey RK, Christen S and Baumgartner
I: Estrogen receptor-a but not -β or GPER inhibits high
glucose-induced human VSMC proliferation: Potential role of ROS and
ERK. J Clin Endocrinol Metab. 96:220–228. 2011. View Article : Google Scholar
|
